Bronchoscope Market: By Type (Flexible Bronchoscope, Rigid Bronchoscope, and Others), By Working Channel Diameter (2.8mm, 2.2mm, 3.0mm, and Others), By Usability (Reusable, Disposable), By Application (Bronchial Diagnosis, Bronchial Treatment), By End Users (Hospitals, Clinics, Ambulatory Care Centers, Others) and Geography

Bronchoscope Market Size was valued at USD 2.73 billion in 2022 and is poised to grow at a CAGR of 7.4% over 2023-2029. The bronchoscope is an instrument used for diagnostic and therapeutic purposes, which is inserted into the airways, usually through the nose or mouth, or occasionally through a tracheostomy, allowing the practitioner to examine the patient’s airways for abnormalities such as foreign bodies, bleeding, tumors, or inflammation. Based on the type, flexible bronchoscope is anticipated to dominate the market share over the forecast period. According to the Forum of International Respiratory Societies report 2022, approximately 200 million people are estimated to have COPD, and 262 million people are affected by asthma. The increasing respiratory disease with the rise in the geriatric population and innovations in the technology of bronchoscopy devices will act as the growth drivers for the market, however, the risk of contamination of devices, and the high overhead cost of bronchoscopy procedures may have a negative impact on the growth of the market. Emerging markets in the Asia Pacific region and increasing government reimbursement policies will be the growth opportunities for players in the market.

Bronchoscope Market Key Developments:

• In May 2022, Premier and Olympus Corporation entered into a group purchasing agreement for Premier’s single-use bronchoscope portfolio.
• In July 2022, Ambu announced that the FDA has granted 510 (k) regulatory clearance to Ambu aScopeTM 5 Broncho, a single-use, sterile bronchoscope.